Iridium Biosciences
Vincent Ling, Ph.D. - Managing Partner LinkedIn Profile
VLing@IridiumBio.com
Vincent Ling, Ph.D, established Iridium Biosciences in 2009 as an organization dedicated to commercializing biotechnology ideas. He has deep experience in biotechnology research and operations, in both domestic and international settings. He is an expert in the design and organization of industrial workflow infrastructures, specializing in protein therapeutics and molecular evolution platforms.
Dr. Ling currently serves as Head of Biological Sciences at Neurotech USA. Neurotech's development programs are based on the Company's proprietary Encapsulated Cell Technology (ECT). ECT uniquely enables the controlled, continuous delivery of biologics directly to the back of the eye, overcoming a major obstacle in the treatment of retinal disease.
As Vice President of Dragonfly Sciences , a US-owned biotechnology contract research organization in China, Dr. Ling created the scientific infrastructure and workflow process for biologics discovery. He hired, assembled, trained, and mentored Chinese scientific work teams to US standards, overseeing the completion of >800 client projects in 3 years. He was an invited speaker at the National Academy of Sciences Symposium on Innovation Capacity in China and India.
As the Director of Molecular Biology at Compound Therapeutics (now Adnexus , a Bristol Myers Squibb Company), Dr. Ling established a high throughput protein therapeutic discovery and engineering platform based on molecular evolution of fibronectin scaffolds against growth factor receptors.
At Wyeth, he was the head of the Molecular Biology Center of Excellence and supported the discovery platform for the immunomodulation program: CTLA4, B7-1, B7-2, B7-H3, PD-1 and ICOS related recombinant protein therapeutics and synthetic antibodies. He served ten years on staff at the Immunology Department at Genetics Institute (now Wyeth), which culminated in three issued patents related to discovery and application of protein therapeutics.
